However, in the plasma of AD patients, changes in Aβ42 levels are opposite to the levels in the CSF and significantly increased [58,59], whereas T-tau and P-tau levels are significantly increased in concordance with the levels in CSF [60,61]. This evidence concerns the gene MAPT and Alzheimer disease.